TABLE 1.
Case | Age at symptoms onset, y | Clinical features at disease onset | Clinical features at treatment onset | Duration of symptoms before treatment onset | Duration since treatment initiation | Treatment benefit | Treatment discontinuation |
---|---|---|---|---|---|---|---|
1 | 26 | Foot dystonia | Dysphagia, dysarthria, oro‐facial dystonia, chorea of upper limb, mild cerebellar signs | 33 y | 62 m | Benefit: +, slight improvement of the last sign that appeared: apathy | Duration of 8 m with rapid degradation |
2 | 46 | Cerebellar syndrome | Cerebellar and extra‐pyramidal syndrome | 11 y | 141 m | Benefit: ++, mild improvement (UPDRS scores from 26 to 19) | 30 m with worsening of gait, balance, extrapyramidal syndrome, depression, apparition of dystonia |
3 | 28 | Spastic paraparesis | Spastic paraparesis | 3 y | 122 m | Benefit: +++, from 1 km to unlimited walking range | 41 m with worsening of spastic paraplegia |
4 | 48 | Extra‐pyramidal and cerebellar syndrome | Extra‐pyramidal and cerebellar syndrome | 4 y | 41 m | Benefit: ++++, improvement of cerebellar signs (SARA from 10 to 4) | No discontinuation |
y = years; m = month.